Loading…
PANADOL BABY AND INFANT is a brand name for Acetaminophen (also known as Paracetamol). The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: Panadol Baby and Infant Suspension is recommended for the relief of pains of teething, toothache and sore throats and for reducing the feverishness often associated with colds and 'flu' and childhood infections such as chicken pox, whooping cough, measles and mumps.
Verbatim from this product's MHRA label. Tap a section to expand.
This product is intended for use in children. It is important to shake the bottle for at least 10 seconds before use. 5 mL spoonful (small end) 4 times 4 – 8 years Two 5 mL spoonfuls (large end) 4 times 8 – 10 years Three 5 mL spoonfuls (large end) 4 times 10 - 12 years Four 5 mL spoonfuls (large end) 4 times • Do not give more than 4 doses in any 24 hour period • Leave at least 4 hours between doses • Do not give this medicine to your child for more than 3 days without speaking to your doctor or pharmacist Method of administration Panadol Baby and Infant Suspension is for oral administration only.
Adverse events of paracetamol from historical clinical trial data are both infrequent and from small patient exposure. Accordingly, events reported from extensive post-marketing experience at therapeutic/labelled dose and considered attributable are tabulated below by system class and frequency.
The following convention has been utilised for the classification of the undesirable effects: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1000 to <1/100), rare (≥1/10,000 to <1/1000) and very rare (<1/10,000), not known (cannot be estimated from available data).
Adverse event frequencies have been estimated from spontaneous reports received through post-marketing data. Post marketing data Body System Undesirable effect Frequency Blood and lymphatic system disorders Thrombocytopenia Agranulocytosis Very rare Immune system disorders Anaphylaxis Cutaneous hypersensitivity reactions including, among others, skin rashes and angiodema.
Very rare cases of serious skin reactions have been reported. 4). Pyroglutamic acidosis may occur as a consequence of low glutathione levels in these patients. ** There have been cases of bronchospasm with paracetamol, but these are more likely in asthmatics sensitive to aspirin or other NSAIDs.
Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App store.
Contains paracetamol. Do not use with any other paracetamol-containing products. Underlying liver disease increases the risk or paracetamol related liver damage. Patients who have been diagnosed with liver or kidney impairment must seek medical advice before taking this medication.
Do not exceed the recommended dose. 9). Use with caution in patients with glutathione depletion due to metabolic deficiencies. g. chronic alcoholism) who were treated with paracetamol at therapeutic dose for a prolonged period or a combination of paracetamol and flucloxacillin.
If HAGMA due to pyroglutamic acidosis is suspected, prompt discontinuation of paracetamol and close monitoring is recommended. The measurement of urinary 5-oxoproline may be useful to identify pyroglutamic acidosis as underlying cause of HAGMA in patients with multiple risk factors.
If symptoms persist, medical advice must be sought. Keep out of the sight and reach of children. If your baby was born prematurely, and is less than 3 months old, consult your doctor prior to use. Patients with rare hereditary problems of fructose intolerance should not take this medicine.
The label should contain the following statements: • Contains paracetamol. • Do not give anything else containing paracetamol while giving this medicineFor oral use only. • Never give more medicine than shown in the table. • Do not overfill the spoon.
• Always use the spoon supplied with the pack. • Do not give to babies less than 2 months of age. • For infants 2-3 months no more than 2 doses should be given. • Do not give more than 4 doses in any 24 hour period. • Leave at least 4 hours between doses.
• Do not give this medicine to your child for more than 3 days without speaking to your doctor or pharmacist. • As with all medicines, if your child is currently taking any medicine consult your doctor or pharmacist before taking this product.
Hypersensitivity to paracetamol or any of the other constituents
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Acetaminophen in United Kingdom.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
• Keep out of the reach and sight of children. • Talk to a doctor at once if your child takes too much of this medicine, even if they seem well (label)Talk to a doctor at once if your child takes too much of this medicine, even if they seem well.
This is because too much paracetamol can cause delayed, serious liver damage (leaflet).